TrialCritical care (London, England)2010

Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated).

Andrew F Shorr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.